ASM Microbe is the largest microbiology meeting in the United States, bringing together thousands of scientists, laboratorians, clinicians, and industry partners to discuss the latest advances in microbiology.

In this episode, Luis shares highlights from ASM Microbe 2026, including sessions on diagnostic challenges, antimicrobial resistance, rapid susceptibility testing, emerging therapeutics, laboratory automation, phage therapy, and whole-genome sequencing. Topics include a Brucella case that reinforces the importance of Gram stain interpretation, updates on resistance mechanisms in Pseudomonas aeruginosa and KPC-producing organisms, advances in rapid AST, and innovations showcased in the vendor hall.

Luis also discusses several posters that caught his attention, covering pharyngeal gonorrhea, direct-from-specimen susceptibility testing, phage testing, rapid resistance reporting for Mycobacterium abscessus, and CRISPR-based diagnostics for bloodstream infections.

Whether you attended ASM Microbe 2026 or couldn't make it this year, this episode provides a practical overview of some of the trends, technologies, and conversations shaping the future of clinical microbiology.

• Diagnostic challenges in clinical microbiology
• Rapid identification and susceptibility testing
• Antimicrobial resistance and emerging therapies
• ESKAPE pathogens and Pseudomonas aeruginosa
• Laboratory automation and AI-assisted workflows
• Phage therapy and phage susceptibility testing
• Whole-genome sequencing and CRISPR diagnostics

Stay connected with Let's Talk Micro:

• Website: letstalkmicro.com

• Questions or feedback? Email me at letstalkmicro@outlook.com

• Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

Support the podcast:

• Venmo

• Buy me a Ko-fi